Resistance to chemotherapy mediated by TrkB in neuroblastomas

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6462-6466

  Ho, Ruth ^a   Eggert, Angelika ^a   Hishiki, Tomoro ^a   Minturn, Jane E ^a   Ikegaki, Naohiko ^a   Foster, Patricia ^a   Camoratto, Anna Marie ^b   Evans, Audrey E ^a   Brodeur, Garrett M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CISPLATIN; DOXORUBICIN; ETOPOSIDE; NERVE GROWTH FACTOR; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ARTICLE; AUTOCRINE EFFECT; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL DEATH; CELL SURVIVAL; CHILDHOOD CANCER; CLONE; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL;

ANTIBODIES; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; NEUROBLASTOMA; PROTEIN-TYROSINE KINASES; RECEPTOR, TRKB; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037112433     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Israel, M. A., Hay, R. J., Park, J. G., and Gazdar, A. Atlas of Human Tumor Cell Lines, pp. 42-78. San Diego: Academic Press, 1994
2. Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J., and Brodeur, G. M. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res., 52: 1364-1368, 1992
3. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastomas. N. Engl. J. Med., 328: 847-854, 1993
4. Nakagawara, A., Azar, C. G., Scavarda, N. J., and Brodeur, G. M. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol., 14: 759-767, 1994
5. Suzuki, T., Bogenmann, E., Shimada, H., Stram, D., and Seeger, R. C. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl. Cancer Inst. (Bethesda), 85: 377-384, 1993
6. Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschella, G., and Persson, H. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res., 53: 2044-2050, 1993
7. Borrello, M. G., Bongarzone, I., Pierotti, M. A., Luksch, R., Gasparini, M., Collini, P., Pilotti, S., Rizzetti, M. G., Mondellini, P., DeBernardi, B., DiMartino, D., Garaventa, A., Brisigotti, M., and Tonini, G. P. TRK and RET protooncogene expression in human neuroblastoma specimens: High-frequency of TRK expression in non-advanced stages. Intl. J. Cancer, 54: 540-545, 1993
8. Yamashiro, D. J., Nakagawara, A., Ikegaki, N., Liu, X-G., and Brodeur, G. M. Expression of TrkC in favorable human neuroblastomas. Oncogene, 12: 37-41, 1996
9. Yamashiro, D. J., Liu, X-G., Lee, C. P., Nakagawara, A., Ikegaki, N., McGregor, L. M., Baylin, S. B., and Brodeur, G. M. Expression and function of TrkC in favourable human neuroblastomas. Eur. J. Cancer, 33: 2054-2057, 1997
10. Ryden, M., Sehgal, R., Dominici, C., Schilling, F. H., Ibanez, C. F., and Kogner, P. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br. J. Cancer, 74: 773-779, 1996
11. Acheson, A., Conover, J. C., Fandi, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., and Lindsay, R. M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature (Lond.), 374: 450-453, 1995
12. TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55: 1798-1806, 1995
13. Middlemas, D. S., Kihl, B. K., and Moody, N. M. Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J. Neurooncol., 45: 27-36, 1999
14. Eggert, A., Brodeur, G. M., and Ikegaki, N. Relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control. Biotechniques, 28: 681-682, 686, 688-691, 2000
15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983
16. Perez-Navarro, E., Canudas, A. M., Akerund, P., Alberch, J., and Arenas, E. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington’s disease. J. Neurochem., 75: 2190-2199, 2000
17. LeMaster, A. M., Krimm, R. F., Davis, B. M., Noel, T., Forbes, M. E., Johnson, J. E., and Albers, K. M. Overexpression of brain-derived neurotrophic factor enhances sensory innervation and selectively increases neuron number. J. Neurosci., 19: 5919-5931, 1999
18. Hetman, M., Kanning, K., Cavanaugh, J. E., and Xia, Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem., 274: 22569-22580, 1999
19. Middlemas, D. S., Kihl, B. K., Zhou, J., and Zhu, X. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J. Biol. Chem., 274: 16451-16460, 1999
20. Feng, X., Jiang, H., Baik, J. C., Edgar, C., and Eide, F. F. BDNF dependence in neuroblastoma. J. Neurosci. Res., 64: 355-363, 2001
21. Aoyama, M., Asai, K., Shishikura, T., Kawamoto, T., Miyachi, T., Yokoi, T., Togari, H., Wada, Y., Kato, T., and Nakagawara, A. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett., 164: 51-60, 2001
22. Kaplan, D. R., and Miller, F. D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol., 10: 381-391, 2000
23. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M. E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms, Science (Wash. DC), 286: 1358-1362, 1999
24. Dolcet, X., Egea, J., Soler, R. M., Martin-Zanca, D., and Comella, J. X. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival. J. Neurochem., 73: 521-531, 1999
25. Encinas, M., Iglesias, M., Llecha, N., and Comella, J. X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem., 73: 1409-1421, 1999
26. Evans, A. E., Kisselbach, K. D., Yamashiro, D. J., Ikegaki, N., Camoratto, A. M., Dionne, C. A., and Brodeur, G. M. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. Clin. Cancer Res., 5: 3594-3602, 1999
27. Evans, A. E., Kisselbach, K. D., Liu, X., Eggert, A., Ikegaki, N., Camoratto, A. M., Dionne, C., and Brodeur, G. M. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med. Pediatr. Oncol., 36: 181-184, 2001